Amgen's most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $165.00 short put and a strike $160.00 long put offers a potential 19.62% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $165.00 by expiration. The full premium credit of $0.82 would be kept by the premium seller. The risk of $4.18 would be incurred if the stock dropped below the $160.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.
The RSI indicator is at 64.66 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition
Thu, 04 Dec 2014 00:26:13 GMT
noodls – THOUSAND OAKS, Calif., Dec. 3, 2014 /PRNewswire/ — Amgen (NASDAQ: AMGN) will host a webcast investor meeting at the American Society of Hematology (ASH) 56th Annual Meeting and Exposition on Monday, Dec. …
Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition
Thu, 04 Dec 2014 00:00:00 GMT
PR Newswire – THOUSAND OAKS, Calif., Dec. 3, 2014 /PRNewswire/ — Amgen (NASDAQ: AMGN) will host a webcast investor meeting at the American Society of Hematology (ASH) 56 th Annual Meeting and Exposition on Monday, …
Amgen gets approval for novel leukemia drug
Wed, 03 Dec 2014 23:14:46 GMT
Amgen gets approval for novel leukemia drug
Wed, 03 Dec 2014 23:14:46 GMT
Actress Adamari López And Amgen Launch Spanish-Language Chemotherapy: Myths Or Facts™ Website And Resources
Wed, 03 Dec 2014 21:58:50 GMT
noodls – THOUSAND OAKS, Calif., Dec. 3, 2014 /PRNewswire/ — Amgen (NASDAQ: AMGN) today launched Quimioterapia: Mitos y Realidades, a Spanish-language extension of the Chemotherapy: Myths or FactsTM awareness initiative …
Related Posts
Also on Market Tamer…
Follow Us on Facebook